Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents
about
RNA replication kinetics, genetic polymorphism and selection in the case of the hepatitis C virusStudy of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virusAssembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, RespectivelyAntiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase.Antiviral effects of an iminosugar derivative on flavivirus infectionsRibonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in CultureIntracellular Assembly and Secretion of Recombinant Subviral Particles from Tick-Borne Encephalitis VirusThe hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivativesDetection of Inhibition of Bovine Viral Diarrhea Virus by Aromatic Cationic MoleculesSynergistic In Vitro Interactions between Alpha Interferon and Ribavirin against Bovine Viral Diarrhea Virus and Yellow Fever Virus as Surrogate Models of Hepatitis C Virus ReplicationThe science, economics, and effectiveness of combination therapy for hepatitis CSuitability of vaccinia virus and bovine viral diarrhea virus (BVDV) for determining activities of three commonly-used alcohol-based hand rubs against enveloped virusesIminosugars in Combination with Interferon and Ribavirin Permanently Eradicate Noncytopathic Bovine Viral Diarrhea Virus from Persistently Infected CellsNovel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against FlavivirusesThe heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivoMinimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig ModelStrain-specific antiviral activity of iminosugars against human influenza A virusesMass spectrometric characterization of proteins from the SARS virus: a preliminary report.Crystal structure of (4R,5S,6R)-6-azido-5-benz-yloxy-3,3,4-tri-fluoro-azepan-1-ium 2,2,2-tri-fluoro-acetate from synchrotron data.Substrate reduction therapy for glycosphingolipid storage disorders.Iminosugars: Promising therapeutics for influenza infection.A novel rare sugar inhibitor of murine herpes simplex keratitis.Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain.Folding of viral envelope glycoproteins in the endoplasmic reticulum.Structure-activity relationship of a new class of anti-hepatitis B virus agents.Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs.Hepatitis C virus therapies: current treatments, targets and future perspectives.Last stop before exit - hepatitis C assembly and release as antiviral drug targets.Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.Recent developments in target identification against hepatitis C virus.Current and emerging therapeutic approaches to hepatitis C infection.Versatility of the endoplasmic reticulum protein folding factory.Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus.Determining the Role of the Aromatic Ring of N-Arylmethyl ent-conduramine F-1 in their Interactions with α-Glucosidases by Saturation Transfer Difference NMR Spectroscopy Experiments.Iminosugar antivirals: the therapeutic sweet spot.Antiviral activity of Bacillus sp. isolated from the marine sponge Petromica citrina against bovine viral diarrhea virus, a surrogate model of the hepatitis C virus.Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection.Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus.
P2860
Q27469492-FC54C568-8DDB-4CE8-826F-6DCED82C189DQ27469853-BD31038E-89EC-4930-B1F8-DABFD29F1FC3Q27469877-9A61DC53-5FF3-45C7-823E-C0E1B79F3B2FQ27469899-33E3BF69-0ADC-4EB5-92B4-31CAA04CAD4BQ27472778-C45866D7-7949-414F-BEA8-358B47DB9D65Q27472863-6A084471-7F0F-452B-9187-0C20C2601C84Q27473305-742403CA-ED93-4FA8-B3A9-4A7FB7E58FEDQ27473375-21161939-3AAC-40BD-A4D2-DEE7D06C11D9Q27477454-27F2D229-6D42-422A-A3FF-AD9BCFC70BDDQ27477550-CF0A26E8-C767-4405-A8CF-A587F544AB8BQ27477551-C4CB8345-7208-4F76-9D4E-A68C0F60435FQ27477845-774C6310-47CE-4716-B6BD-D942B257C964Q27478098-005577E4-8BB8-4677-BB6D-A1182B3ABEACQ27485894-0EA0830A-CB5A-44FC-86A5-C99C7C5B10F0Q27488274-0170B751-17DD-4DA9-8657-53A426A870DCQ28142779-EA1BFD96-944C-4313-ABDA-ACC6B09181E1Q28553683-1D6AFC7F-9165-4285-8C89-0B0F0158066CQ30366818-8842CD61-EF90-442F-B588-6A02469EF88FQ30939828-5E69FFE0-DED6-4B15-B439-3B8ABBA2DD42Q31027235-C17E924E-E09B-4998-B00C-696705157D55Q32066333-F9E353DF-5189-4294-9264-CC1700396DC5Q33795341-3DB1A80B-CAAC-423F-B295-FC0D822D0087Q33878577-A6F7ABA2-8237-4136-8128-95E78EA80F11Q33879577-90FCC3FB-FF55-4ECD-9E84-C3944BB2C19CQ34156701-F2D85D13-7577-4668-BEAA-9E80E7881998Q34251931-D396420D-2F8A-4DE6-B77F-37463A4D51C3Q34557737-9B0F0582-9330-4E84-8714-B3DF6E58B653Q34644755-CACF9FF8-1994-4A81-A3CF-C31DA93F7FEFQ35147050-B4D3893C-988A-47CF-9929-631441E64C71Q35261158-874E0DF9-C28A-46FF-9E52-35C7A8DB5478Q35548601-DE0034BD-82D0-4BF3-85C8-A9B510B4DB7AQ35842500-65E7DCC5-AEB0-48C0-A960-1452CE53BE5DQ35917244-2AC72D26-DFE6-491C-94F2-4888352CC0D3Q36242585-4557ED2F-59FF-4563-9067-1A6BB4990436Q36363294-2779A89A-BDC4-4E1E-931C-944087E8F3BBQ37580361-D9E5B4DF-EF6F-4CD6-9D7D-B8692C5B7998Q38730551-32675354-B9C4-41E7-8383-8402CB4C6CB9Q39158546-52CB846D-C0A1-4C43-86B2-AE36282F28F8Q39328622-16FE8AD2-8AD5-4E75-9186-E34AEABE982EQ40160028-5588A187-BA93-4A4E-90BB-CEF3010F5AA8
P2860
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@ast
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@en
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@nl
type
label
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@ast
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@en
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@nl
prefLabel
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@ast
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@en
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@nl
P2093
P2860
P356
P1476
Imino sugars inhibit the forma ...... um anti-hepatitis virus agents
@en
P2093
B S Blumberg
J McCauley
N Zitzmann
S Carrouée
T D Butters
P2860
P304
P356
10.1073/PNAS.96.21.11878
P407
P577
1999-10-12T00:00:00Z